IRIS
BARBIERI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.798
AS - Asia 1.722
NA - Nord America 1.657
Continente sconosciuto - Info sul continente non disponibili 352
SA - Sud America 170
AF - Africa 27
OC - Oceania 6
Totale 19.732
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.512
US - Stati Uniti d'America 1.552
SG - Singapore 699
CN - Cina 397
VN - Vietnam 273
BD - Bangladesh 164
FR - Francia 118
BR - Brasile 96
HK - Hong Kong 67
CA - Canada 41
FI - Finlandia 33
DE - Germania 31
AR - Argentina 30
MX - Messico 25
IQ - Iraq 21
GB - Regno Unito 20
IN - India 17
JP - Giappone 14
CH - Svizzera 13
CO - Colombia 13
ID - Indonesia 11
NL - Olanda 11
ES - Italia 10
EC - Ecuador 9
PK - Pakistan 8
CL - Cile 7
HN - Honduras 7
KE - Kenya 7
PL - Polonia 7
RU - Federazione Russa 7
VE - Venezuela 7
JM - Giamaica 6
PH - Filippine 6
TH - Thailandia 6
UA - Ucraina 6
AU - Australia 5
GT - Guatemala 5
IE - Irlanda 5
TR - Turchia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
JO - Giordania 4
PY - Paraguay 4
SV - El Salvador 4
ZA - Sudafrica 4
AT - Austria 3
BH - Bahrain 3
DK - Danimarca 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
PR - Porto Rico 3
RS - Serbia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GR - Grecia 2
IL - Israele 2
LV - Lettonia 2
MQ - Martinica 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
TN - Tunisia 2
TZ - Tanzania 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EG - Egitto 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MM - Myanmar 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
SE - Svezia 1
SN - Senegal 1
SO - Somalia 1
SY - Repubblica araba siriana 1
VI - Stati Uniti Isole Vergini 1
WS - Samoa 1
Totale 19.381
Salva come PNG Salva come JPEG
Città #
Genova 8.444
Genoa 4.600
Vado Ligure 1.220
Rapallo 997
San Jose 405
Singapore 346
Ashburn 207
Lauterbourg 101
Beijing 84
Ho Chi Minh City 71
Council Bluffs 69
Hanoi 68
Hong Kong 65
New York 62
Santa Clara 40
Bordighera 33
Helsinki 28
Los Angeles 27
Milan 27
Haiphong 26
Frankfurt am Main 23
Rome 23
Chicago 22
Mexico City 19
Atlanta 14
Tokyo 13
Boardman 12
São Paulo 12
Da Nang 11
Amsterdam 10
Zurich 10
Tianjin 9
Baghdad 8
Biên Hòa 7
Bologna 7
Charlotte 7
Dallas 7
Florence 7
Houston 7
Hải Dương 7
Las Vegas 7
Montreal 7
Phoenix 7
Warsaw 7
Buffalo 6
London 6
Nairobi 6
Palermo 6
Princeton 6
Toronto 6
Turin 6
Brooklyn 5
City of London 5
Clearwater 5
Denver 5
Guatemala City 5
Lappeenranta 5
Madrid 5
Nha Trang 5
Shanghai 5
Vignate 5
Baku 4
Belo Horizonte 4
Buenos Aires 4
Detroit 4
Dublin 4
Jacksonville 4
Jakarta 4
Medellín 4
Memphis 4
Minneapolis 4
Newark 4
Nuremberg 4
Orem 4
Parma 4
Philadelphia 4
Piscataway 4
Queens 4
Quito 4
San José 4
San Salvador 4
Santiago 4
The Dalles 4
Amman 3
Auberville 3
Bangkok 3
Belgrade 3
Calgary 3
Can Tho 3
Cardiff 3
Chula Vista 3
Cleveland 3
Curitiba 3
Dearborn 3
Des Moines 3
East Orange 3
Erbil 3
Fresno 3
Greenville 3
Guangzhou 3
Totale 17.414
Salva come PNG Salva come JPEG
Nome #
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 268
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 257
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 256
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells 246
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 245
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 241
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 239
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors 227
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 226
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity 225
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 219
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 216
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 212
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 212
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 205
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity 204
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors 204
Chemokines and chemokine receptors: New actors in neuroendocrine regulations 203
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 202
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 201
1,4-bis(1-naphtyl)-2,3-dinitro-1,3 butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance. 200
Endometrial stem cells and human reproductive failure 197
Drug-repositioning opportunities for cancer therapy: Novel molecular targets for known compounds 195
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma 193
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 192
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 191
Glioblastoma cancer stem cells: response to epidermal growth factor receptor kinase inhibitors 190
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 189
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 188
Antisense oligonucleotides as therapeutic agents. 188
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 187
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 186
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 185
Differential efficacy of SSTR1, 2 and 5 agonists in the inhibition of C6 glioma growth in nude mice 185
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 180
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 180
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 180
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 178
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 177
Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of Phidianidine A as a new CXCR4 ligand exhibiting antagonist activity 177
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 173
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 172
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 172
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity 171
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 171
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 169
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis 168
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 167
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 166
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 164
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 162
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 162
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 162
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 162
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential 161
Expression of cyclin D1 correlates with malignancy in human ovarian tumours 160
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment 159
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study 158
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits 156
Biomimetic vesicles for glioblastoma treatment 156
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 155
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer. 153
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 153
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies 153
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells 152
Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells 152
Amyloid-beta Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau 150
A liposomal formulation for inflammation targeting 149
Ruta graveolens water extract inhibits cell-cell network formation in human umbilical endothelial cells via MEK-ERK1/2 pathway 148
Antiproliferative effect of DNA polymerase antisense oligodeoxynucleotides on breast cancer cells. 144
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 144
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity 144
Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases 143
The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells 143
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 142
Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment 141
The use of antisense oligodeoxynucleotides (aODNs) in immunopharmacology. 141
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells 141
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 140
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines. 140
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 140
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer 138
Somatostatin and somatostatin receptors 1, 2 and 5 selective agonists inhibit C6 glioma cell growth in vitro and in vivo: Analysis of activated intracellular pathways 135
Control of gene expression by triplex forming oligonucleotides in human live cells. 135
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 134
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells 133
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas. 132
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract 130
Goat anti-human GM-CSF recognizes canine GM-CSF 130
Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin (IV) lupinylsulfide hydrochloride. 125
Thymidine Labelling Index as prognostic factor in resected non-small cell lung cancer. 124
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferaton and migration. 122
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in Ovarian tumors 122
Expression of somatostatin receptors mRNA in human meningiomas and their implication in in vitro antiproliferative activity 118
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target 118
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 115
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound 114
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 113
Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues 107
Expression of calpastatin hcast 3-25 and activity of the calpain/calpastatin system in human glioblastoma stem cells: possible involvement of hcast 3-25 in cell differentiation 107
Totale 16.957
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.684
article - articoli 56.948
book - libri 0
conference - conferenze 3.244
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 492
Totale 121.368
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.381 55 124 73 165 35 102 95 310 66 111 58 187
2022/20231.210 108 82 14 128 147 223 1 106 209 16 149 27
2023/2024897 49 85 21 103 55 192 76 50 41 29 70 126
2024/20253.088 111 180 100 243 391 346 278 614 117 128 261 319
2025/20265.345 626 137 581 446 618 370 654 250 474 501 288 400
2026/2027463 463 0 0 0 0 0 0 0 0 0 0 0
Totale 19.732